Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
70%
Total
Publications
63
Total Open
Publications
44
Total
Citations
815
Open Access
Percentage
70%
Total
Publications
63
Total Open
Publications
44
Total
Citations
815
Breakdown
Publisher Open
39%
Both
23%
Other Platform Open
5%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 60%
21
Hybrid 23%
8
No Guarantees 17%
6
Other Platform Open
Domain 50%
10
Institution 40%
8
Public 20%
4
Preprint 5%
1
Other Internet 5%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 10 |
University of Melbourne - Minerva Access | Institution | 2 |
Open Research Library | Public | 2 |
Figshare | Public | 2 |
Unknown Repository | Other Internet | 1 |
University of Minnesota, USA - AgEcon Search | Institution | 1 |
University of KwaZulu-Natal - ResearchSpace | Institution | 1 |
Universitat Jaume I - Repositori UJI | Institution | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |
OSF Preprints - Arabixiv | Preprint | 1 |